Loading company…
M3TRIQ develops AI tools for adapting antibodies between species while preserving binding efficacy.
M3TRIQ develops AMPSA, an AI system that adapts antibodies across species while preserving antigen binding, for use in drug development, protein engineering and molecular discovery. Founded in 2025, the company is based in Kuala Lumpur, Malaysia. On August 6, 2025, it raised MYR 110,000 in pre-seed funding from Antler.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in